Published online before print September 7, 2007
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Article |
Servicio de Inmunología and Unidad de Investigación, Hospital Universitario Puerta del Mar, Cádiz, Spain
@ To whom correspondence should be addressed. E-mail: josea.brieva.sspa{at}juntadeandalucia.es.
Human plasma cells (PC) are present in cell suspensions obtained from the tonsil by mechanical disaggregation (PCMECH). The present study shows that a collagenase treatment of tonsillar debris remaining after mechanical disaggregation yielded similar proportions of PC (PCCOLL). Moreover, PCMECH were present in suspensions highly enriched in germinal center cells whereas PCCOLL contained most of the IgA-secreting cells, suggesting their predominant location in follicular and parafollicular areas and connective tissue-rich zones such as tonsil subepithelium, respectively. Tonsil PCMECH and PCCOLL shared the phenotype CD38high CD19+ CD20low CD45high, expressed equivalent amounts of PRDI BF1/Blimp-1 transcription factor, and carried similarly mutated IgVH6 genes. However, they differed in several features. 1) PCMECH still expressed the early B cell transcription factor BSAP and were HLA-DRhigh; in contrast, PCCOLL were BSAP-and HLA-DRlow. 2) PCMECH were CD95+ and Bcl-2+/- whereas PCCOLL showed CD95+/- and Bcl-2+ expression; in addition, PCMECH exhibited increased spontaneous apoptosis. 3) The two PC subsets exhibited distinctive adhesion molecule profiles, since PCCOLL expressed higher levels of CD31, CD44, and CD49d, but a lower level of CD11a than PCMECH. These results suggest that PCMECH are recently generated, short-living PC, and PCCOLL constitutes a subset with higher maturity and survival, which resides in connective tissue-rich areas.
Key Words: PC biology adhesion molecule B cell transcription factor differentiation
This article has been cited by other articles:
![]() |
G. Jimenez-Gomez, J. L. Gomez-Perales, A. Ramos-Amaya, I. Gonzalez-Garcia, A. Campos-Caro, and J. A. Brieva Modulated selection of IGHV gene somatic hypermutation during systemic maturation of human plasma cells J. Leukoc. Biol., March 1, 2010; 87(3): 523 - 530. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Jourdan, A. Caraux, J. De Vos, G. Fiol, M. Larroque, C. Cognot, C. Bret, C. Duperray, D. Hose, and B. Klein An in vitro model of differentiation of memory B cells into plasmablasts and plasma cells including detailed phenotypic and molecular characterization Blood, December 10, 2009; 114(25): 5173 - 5181. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. K. Arendt, M. Ramirez-Alvarado, L. A. Sikkink, J. J. Keats, G. J. Ahmann, A. Dispenzieri, R. Fonseca, R. P. Ketterling, R. A. Knudson, E. M. Mulvihill, et al. Biologic and genetic characterization of the novel amyloidogenic lambda light chain-secreting human cell lines, ALMC-1 and ALMC-2 Blood, September 1, 2008; 112(5): 1931 - 1941. [Abstract] [Full Text] [PDF] |
||||